Insulin glargine and lixisenatide and Sirturo Tablets
Determining the interaction of Insulin glargine and lixisenatide and Sirturo Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: bedaquiline
Brand name: Sirturo
Synonyms: Bedaquiline, Bedaquiline Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Sitagliptin
- Insulin glargine and lixisenatide-Sitagliptin and metformin
- Insulin glargine and lixisenatide-Sitagliptin and Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide-Sitagliptin and Metformin Tablets
- Insulin glargine and lixisenatide-Sitagliptin and simvastatin
- Insulin glargine and lixisenatide-Sitagliptin Phosphate
- Sirturo Tablets-Insulin glargine and lixisenatide Subcutaneous
- Sirturo Tablets-Insulin glargine, recombinant Subcutaneous
- Sirturo Tablets-Insulin glulisine
- Sirturo Tablets-Insulin Glulisine (Cartridges and Pens)
- Sirturo Tablets-Insulin Glulisine (Vials)
- Sirturo Tablets-Insulin glulisine Subcutaneous